The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways

In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells...

Full description

Bibliographic Details
Main Author: Khan, Md Shamsuddin Sultan
Format: Thesis
Language:English
Published: 2017
Subjects:
Online Access:http://eprints.usm.my/47701/
http://eprints.usm.my/47701/1/THE%20DEVELOPMENT%20OF%20ROSMARINIC%20ACID.pdf%20cut.pdf
_version_ 1848880950118711296
author Khan, Md Shamsuddin Sultan
author_facet Khan, Md Shamsuddin Sultan
author_sort Khan, Md Shamsuddin Sultan
building USM Institutional Repository
collection Online Access
description In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells. Antiangiogenic activity was investigated with tube formation, CAM, and aortic explant assays. The compounds’ activity in IL17A and VEGF expression was determined using ELISA and their apoptotic activity was assessed by the Caspase assay. The cancer pathway was determined using the reporter gene assay.
first_indexed 2025-11-15T18:11:16Z
format Thesis
id usm-47701
institution Universiti Sains Malaysia
institution_category Local University
language English
last_indexed 2025-11-15T18:11:16Z
publishDate 2017
recordtype eprints
repository_type Digital Repository
spelling usm-477012020-10-22T08:34:47Z http://eprints.usm.my/47701/ The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways Khan, Md Shamsuddin Sultan RS1-441 Pharmacy and materia medica In this study, glioblastoma inhibition was acheived via the disruption of IL17A, which blocks angiogenesis using new derivatives of rosmarinic acid (RA). Anti-GBM activity of the compounds were determined through cell migration and cell proliferation assays with U87 MG, DBTRG MG, and EA.hy 926 cells. Antiangiogenic activity was investigated with tube formation, CAM, and aortic explant assays. The compounds’ activity in IL17A and VEGF expression was determined using ELISA and their apoptotic activity was assessed by the Caspase assay. The cancer pathway was determined using the reporter gene assay. 2017-09 Thesis NonPeerReviewed application/pdf en http://eprints.usm.my/47701/1/THE%20DEVELOPMENT%20OF%20ROSMARINIC%20ACID.pdf%20cut.pdf Khan, Md Shamsuddin Sultan (2017) The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways. PhD thesis, Universiti Sains Malaysia.
spellingShingle RS1-441 Pharmacy and materia medica
Khan, Md Shamsuddin Sultan
The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_full The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_fullStr The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_full_unstemmed The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_short The Development Of Rosmarinic Acid Derivatives To Target Il17a In Glioblastoma Multiforme Via Angiogenic Pathways
title_sort development of rosmarinic acid derivatives to target il17a in glioblastoma multiforme via angiogenic pathways
topic RS1-441 Pharmacy and materia medica
url http://eprints.usm.my/47701/
http://eprints.usm.my/47701/1/THE%20DEVELOPMENT%20OF%20ROSMARINIC%20ACID.pdf%20cut.pdf